The Human Immunodeficiency Virus (HIV) is a retrovirus that attacks the immune system, specifically CD4 cells, which play a crucial role in the body's defense against infections. HIV can lead to Acquired Immunodeficiency Syndrome (AIDS), a condition characterized by a weakened immune system, making individuals more susceptible to opportunistic infections and certain cancers. HIV is primarily transmitted through unprotected sexual intercourse, contaminated blood or blood products, and from an infected mother to her child during childbirth or breastfeeding. The virus can also be spread through sharing of needles among intravenous drug users. Antiretroviral therapy (ART) has revolutionized the management of HIV, helping control viral replication and allowing individuals with HIV to lead healthy lives. Despite advancements, there is no cure for HIV, making prevention through safe practices, testing, and awareness crucial. Global efforts focus on reducing new HIV infections, increasing access to treatment, and combating stigma associated with the virus. HIV/AIDS awareness campaigns promote education, testing, and destigmatization, emphasizing the importance of early diagnosis and ongoing research toward a cure.
Khursheed Anwer
IMUNON, United States
Ping Xie
Rutgers University, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Lara Isis Teodoro
Mayo Clinic, United States
Ahmed Abdulazeez
BHRUT Trust, United Kingdom
Elena Chiappini
University of Florence, Italy
Ayesha Zahid
Griffith University, Australia
Livia Daflon Silva
Federal University of State of Rio de Janeiro, Brazil
Neha Bhandari
Chitkara University, IndiaSubmit your abstract Today
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States